Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 529
Filtrar
Más filtros

Intervalo de año de publicación
1.
Curr Opin Anaesthesiol ; 37(3): 234-238, 2024 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-38390913

RESUMEN

PURPOSE OF REVIEW: Postpartum anemia (PPA) is common in women after childbirth and affects about 50-80% of all women worldwide. Iron deficiency (ID) is the main cause for anemia and constitutes a potentially preventable condition with great impact on the mother's physical and mental condition after delivery. In most cases, PPA is associated with antenatal ID and peripartum blood losses. Numerous published studies confirmed the positive effect of PPA diagnosis and treatment. RECENT FINDINGS: Iron deficiency as well as iron deficiency anemia (IDA) are common in the postpartum period and represent significant health problems in women of reproductive age. SUMMARY: Important movements towards early detection and therapy of postpartum anemia have been observed. However, postpartum anemia management is not implemented on a large scale as many healthcare professionals are not aware of the most recent findings in the field. Diagnosis and therapy of PPA, particularly iron supplementation in ID and IDA, has proven to be highly effective with a tremendous effect on women's wellbeing and outcome.


Asunto(s)
Anemia Ferropénica , Humanos , Femenino , Anemia Ferropénica/diagnóstico , Anemia Ferropénica/terapia , Anemia Ferropénica/etiología , Embarazo , Anemia/terapia , Anemia/diagnóstico , Anemia/etiología , Hierro/uso terapéutico , Hierro/administración & dosificación , Periodo Posparto , Trastornos Puerperales/terapia , Trastornos Puerperales/diagnóstico , Trastornos Puerperales/etiología , Suplementos Dietéticos , Deficiencias de Hierro/diagnóstico , Deficiencias de Hierro/terapia
3.
Psicol. ciênc. prof ; 43: e244244, 2023.
Artículo en Portugués | LILACS, INDEXPSI | ID: biblio-1448957

RESUMEN

Com os avanços tecnológicos e o aprimoramento da prática médica via ultrassonografia, já é possível detectar possíveis problemas no feto desde a gestação. O objetivo deste estudo foi analisar a prática do psicólogo no contexto de gestações que envolvem riscos fetais. Trata-se de um estudo qualitativo sob formato de relato de experiência como psicólogo residente no Serviço de Medicina Fetal da Maternidade Escola da Universidade Federal do Rio de Janeiro (UFRJ). Os registros, feitos por observação participante e diário de campo, foram analisados em dois eixos temáticos: 1) intervenções psicológicas no trabalho em equipe em consulta de pré-natal, exame de ultrassonografia e procedimento de amniocentese; e 2) intervenções psicológicas em casos de bebês incompatíveis com a vida. Os resultados indicaram que o psicólogo nesse serviço é essencial para atuar de forma multiprofissional na assistência pré-natal para gravidezes de alto risco fetal. Ademais, a preceptoria do residente é relevante para sua formação e treinamento para atuação profissional no campo da psicologia perinatal.(AU)


Face to the technological advances and the improvement of medical practice via ultrasound, it is already possible to detect possible problems in the fetus since pregnancy. The objective of this study was to analyze the psychologist's practice in the context of pregnancies which involve fetal risks. It is a qualitative study based on an experience report as a psychologist trainee at the Fetal Medicine Service of the Maternity School of UFRJ. The records, based on the participant observation and field diary, were analyzed in two thematic axes: 1) psychological interventions in the teamwork in the prenatal attendance, ultrasound examination and amniocentesis procedure; and 2) psychological interventions in cases of babies incompatible to the life. The results indicated that the psychologist in this service is essential to work in a multidisciplinary way at the prenatal care for high fetal risk pregnancies. Furthermore, the resident's preceptorship is relevant to their education and training for professional performance in the field of Perinatal Psychology.(AU)


Con los avances tecnológicos y la mejora de la práctica médica a través de la ecografía, ya se puede detectar posibles problemas en el feto desde el embarazo. El objetivo de este estudio fue analizar la práctica del psicólogo en el contexto de embarazos de riesgos fetal. Es un estudio cualitativo basado en un relato de experiencia como residente de psicología en el Servicio de Medicina Fetal de la Escuela de Maternidad de la Universidade Federal do Rio de Janeiro (UFRJ). Los registros, realizados en la observación participante y el diario de campo, se analizaron en dos ejes temáticos: 1) intervenciones psicológicas en el trabajo en equipo, en la consulta prenatal, ecografía y los procedimientos de amniocentesis; y 2) intervenciones psicológicas en casos de bebés incompatibles con la vida. Los resultados señalaron como fundamental la presencia del psicólogo en este servicio trabajando de forma multidisciplinar en la atención prenatal en el contexto de embarazos de alto riesgo fetal. Además, la tutela del residente es relevante para su educación y formación para el desempeño profesional en el campo de la Psicología Perinatal.(AU)


Asunto(s)
Humanos , Femenino , Embarazo , Atención Prenatal , Embarazo de Alto Riesgo , Intervención Psicosocial , Cardiopatías Congénitas , Ansiedad , Orientación , Dolor , Relaciones Padres-Hijo , Padres , Paternidad , Grupo de Atención al Paciente , Pacientes , Pediatría , Placenta , Placentación , Complicaciones del Embarazo , Mantenimiento del Embarazo , Pronóstico , Teoría Psicoanalítica , Psicología , Trastornos Puerperales , Calidad de Vida , Radiación , Religión , Reproducción , Fenómenos Fisiológicos Reproductivos y Urinarios , Cirugía General , Síndrome , Anomalías Congénitas , Templanza , Terapéutica , Sistema Urogenital , Bioética , Consultorios Médicos , Recien Nacido Prematuro , Trabajo de Parto , Embarazo , Preñez , Resultado del Embarazo , Adaptación Psicológica , Preparaciones Farmacéuticas , Ecocardiografía , Espectroscopía de Resonancia Magnética , Familia , Aborto Espontáneo , Crianza del Niño , Protección a la Infancia , Salud Mental , Salud de la Familia , Tasa de Supervivencia , Esperanza de Vida , Causas de Muerte , Ultrasonografía Prenatal , Mapeo Cromosómico , Permiso Parental , Competencia Mental , Riñón Poliquístico Autosómico Recesivo , Síndrome de Down , Atención Perinatal , Atención Integral de Salud , Compuestos Químicos , Depresión Posparto , Manifestaciones Neuroconductuales , Niños con Discapacidad , Técnicas y Procedimientos Diagnósticos , Número de Embarazos , Intervención en la Crisis (Psiquiatría) , Afecto , Análisis Citogenético , Espiritualidad , Complicidad , Valor de la Vida , Parto Humanizado , Muerte , Toma de Decisiones , Mecanismos de Defensa , Amenaza de Aborto , Atención a la Salud , Demencia , Incertidumbre , Organogénesis , Investigación Cualitativa , Mujeres Embarazadas , Diagnóstico Precoz , Nacimiento Prematuro , Medida de Translucencia Nucal , Mortalidad del Niño , Depresión , Trastorno Depresivo , Periodo Posparto , Diagnóstico , Técnicas de Diagnóstico Obstétrico y Ginecológico , Etanol , Ego , Emociones , Empatía , Ambiente , Humanización de la Atención , Acogimiento , Ética Profesional , Forma del Núcleo Celular , Nutrición Prenatal , Medición de Longitud Cervical , Conflicto Familiar , Terapia Familiar , Resiliencia Psicológica , Fenómenos Fisiológicos Reproductivos , Enfermedades Urogenitales Femeninas y Complicaciones del Embarazo , Saco Gestacional , Evento Inexplicable, Breve y Resuelto , Muerte Fetal , Desarrollo Embrionario y Fetal , Imagen Multimodal , Mortalidad Prematura , Toma de Decisiones Clínicas , Medicina de Urgencia Pediátrica , Niño Acogido , Libertad , Agotamiento Psicológico , Entorno del Parto , Frustación , Tristeza , Respeto , Distrés Psicológico , Genética , Bienestar Psicológico , Obstetras , Culpa , Felicidad , Empleos en Salud , Hospitalización , Maternidades , Hospitales Universitarios , Desarrollo Humano , Derechos Humanos , Imaginación , Infecciones , Infertilidad , Anencefalia , Jurisprudencia , Complicaciones del Trabajo de Parto , Concesión de Licencias , Acontecimientos que Cambian la Vida , Cuidados para Prolongación de la Vida , Soledad , Amor , Cuerpo Médico de Hospitales , Discapacidad Intelectual , Principios Morales , Madres , Narcisismo , Enfermedades y Anomalías Neonatales Congénitas y Hereditarias , Neonatología , Malformaciones del Sistema Nervioso , Apego a Objetos
4.
J Matern Fetal Neonatal Med ; 35(25): 8982-8988, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34844500

RESUMEN

PURPOSE: Treatment for post-partum anemia frequently entails oral iron supplementation, but questions remain regarding optimal dosing, frequency, and efficacy. The objective of this study was to describe oral iron prescribing practices in post-partum women delivered via Cesarean section, and identify factors associated with iron supplementation. METHODS: A retrospective review of Cesarean section deliveries at a single tertiary center between May 2019 and April 2020 was undertaken. Patient demographics, hematological indices, indication for Cesarean section and discharge prescriptions were collected. Univariate and multivariable analyses were performed to identify factors associated with oral iron prescription at discharge. RESULTS: During the study period, 1470 women were eligible for inclusion. The mean age at delivery was 34.4 ± 4.9 years and mean gestational age was 37.2 ± 3.6 weeks. Most pregnancies (92%) were singleton. Ninety-six total patients (6.5%) received intravenous iron post-partum. Fourteen percent of women (210/1470) received prescriptions for oral iron at discharge, most commonly ferrous fumarate (61.9%, 130/210). The most common dose provided was 300 mg (145/210). Ante-partum ferritin was available for most patients (64.3%, 945/1470), but only for 17 post-partum patients (1.2%). Factors significantly associated with oral iron prescription were earlier gestational age at birth (aOR 0.93, 95% CI 0.89-0.97), history of complications during pregnancy or labor (aOR 1.92, 95% CI 1.26-2.98), higher blood loss (aOR 2.66, 95% CI 1.36-5.44), post-partum anemia (aOR 6.28, 95%-CI 4.41-8.96), blood transfusion (aOR 5.43, 95%-CI 1.81-18.19) and antenatal iron supplementation (aOR 5.70, 95%-CI 4.02-8.17). CONCLUSIONS: In summary, a relatively small proportion of women following Cesarean section were prescribed oral iron at discharge. We identified several factors associated with post-partum iron supplementation. This information will inform future prospective studies investigating the efficacy of iron supplementation in the treatment of post-partum anemia.


Asunto(s)
Anemia Ferropénica , Anemia , Trastornos Puerperales , Recién Nacido , Femenino , Embarazo , Humanos , Lactante , Hierro/uso terapéutico , Estudios Retrospectivos , Cesárea/efectos adversos , Estudios Prospectivos , Anemia/tratamiento farmacológico , Anemia/etiología , Periodo Posparto , Suplementos Dietéticos , Anemia Ferropénica/tratamiento farmacológico , Anemia Ferropénica/complicaciones
5.
Am J Obstet Gynecol MFM ; 4(2): 100533, 2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-34808403

RESUMEN

BACKGROUND: In randomized trials, antepartum intravenous iron sucrose is effective at improving predelivery hemoglobin in iron deficiency anemia. Yet, there is a gap between this knowledge and its implementation into care. OBJECTIVE: We aimed to determine if the implementation of a standardized protocol for the management of antepartum anemia outside of a clinical trial improves intravenous iron sucrose utilization and clinical outcomes. STUDY DESIGN: We performed a prospective cohort study evaluating the incorporation of an anemia protocol into routine clinical care for women with antepartum hemoglobin <11.0 g/dL. Our protocol, developed with multidisciplinary stakeholders, included (1) serial third trimester hemoglobin assessment, (2) oral iron supplementation for antepartum hemoglobin 9.5-11 g/dL, and (3) antepartum intravenous iron sucrose use (300 mg weekly for 3 weeks) for hemoglobin <9.5 g/dL. We compared 6-months preimplementation (January 2018 to June 2018) to 6-months postimplementation (January 2019 to June 2019). The outcomes evaluated were antepartum intravenous iron sucrose utilization, the number of intravenous iron sucrose dosages, predelivery hemoglobin, and blood transfusion. RESULTS: A total of 1423 women were included (pre=778; post=645) without significant baseline differences. The antepartum hemoglobin nadir was no different between the groups (pre: 10.2; interquartile range [9.6-10.6] vs post: 10.2; interquartile range [9.6-10.6]; P=.77). The implementation of a standardized protocol for the management of antepartum anemia was associated with 80% increased odds of receiving intravenous iron sucrose than the preimplementation group (pre: 4.8% vs post: 8.2%, P=.008; odds ratio, 1.79; 95% confidence interval, [1.16-2.77]). The implementation of a standardized protocol for the management of antepartum iron deficiency anemia was also associated with higher hemoglobin at admission for delivery (pre: 10.9; interquartile range [10.1-11.6] vs post: 11.0; interquartile range [10.3-11.7], P=.048). There were no significant differences between the groups in blood product transfusion (pre: 7.1% vs post: 5.1%, P=.13). CONCLUSION: Implementation of a standardized antepartum anemia protocol is associated with increased intravenous iron sucrose utilization and improvement in predelivery hemoglobin.


Asunto(s)
Anemia Ferropénica , Anemia , Hematínicos , Deficiencias de Hierro , Trastornos Puerperales , Anemia/diagnóstico , Anemia/tratamiento farmacológico , Anemia/epidemiología , Anemia Ferropénica/diagnóstico , Anemia Ferropénica/tratamiento farmacológico , Anemia Ferropénica/epidemiología , Femenino , Compuestos Férricos/uso terapéutico , Sacarato de Óxido Férrico/uso terapéutico , Hematínicos/uso terapéutico , Hemoglobinas/análisis , Hemoglobinas/metabolismo , Hemoglobinas/uso terapéutico , Humanos , Masculino , Estudios Prospectivos , Trastornos Puerperales/tratamiento farmacológico , Resultado del Tratamiento
6.
Am J Obstet Gynecol ; 225(6): 668.e1-668.e9, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34171389

RESUMEN

BACKGROUND: Studies that have compared the effectiveness of oral with intravenous iron supplements to treat postpartum anemia have shown mixed results. The superiority of one mode of treatment vs the other has yet to be demonstrated. Therefore, despite guidelines and standards of care, treatment approaches vary across practices. A single 500 mg dose of iron sucrose, which is higher than what is usually administered, has not been evaluated to treat postpartum moderate to severe anemia. OBJECTIVE: This study aimed to compare the efficacy of intravenous iron sucrose alone with intravenous iron sucrose in combination with oral iron bisglycinate supplementation in treating moderate to severe postpartum anemia. STUDY DESIGN: A randomized controlled trial was conducted between February 2015 and June 2020. Women with postpartum hemoglobin level of ≤9.5 g/dL were treated with 500 mg intravenous iron sucrose after an anemia workup, which ruled out other causes for anemia. In addition to receiving intravenous iron, women were randomly allocated to receive either 60 mg of oral iron bisglycinate for 45 days or no further iron supplementation. The primary outcome was hemoglobin level at 6 weeks after delivery. Secondary outcomes were iron storage parameters and quality of life. RESULTS: Of 158 patients who participated, 63 women receiving intravenous and oral iron, and 44 women receiving intravenous iron-only, completed the study and were included in the analysis. Baseline and obstetrical characteristics were similar between the study cohorts. Although statistically significant, postpartum hemoglobin levels were only 0.4 g/dL higher in the intravenous and oral iron than intravenous iron-only cohort (12.4 g/dL vs 12.0 g/dL, respectively; P=.03), with a respective increase from baseline of 4.2 g/dL vs 3.7 g/dL (P=.03). There was no difference in the rate of women with hemoglobin level of <12.0 or 11.0 g/dL. Iron storage and health quality were not different between the cohorts. Oral iron treatment was associated with 29% rate of adverse effects. Compliance and satisfaction from treatment protocol were high in both cohorts. CONCLUSION: Intravenous 500 mg iron sucrose treatment alone is sufficient to treat postpartum anemia without the necessity of adding oral iron treatment.


Asunto(s)
Anemia Ferropénica/tratamiento farmacológico , Compuestos Ferrosos/uso terapéutico , Hematínicos/uso terapéutico , Atención Prenatal , Trastornos Puerperales/tratamiento farmacológico , Administración Oral , Adulto , Femenino , Compuestos Ferrosos/administración & dosificación , Hematínicos/administración & dosificación , Humanos , Infusiones Intravenosas , Embarazo , Estudios Prospectivos , Resultado del Tratamiento
7.
Medicine (Baltimore) ; 100(23): e25511, 2021 Jun 11.
Artículo en Inglés | MEDLINE | ID: mdl-34114980

RESUMEN

BACKGROUND: Female pelvic floor dysfunction is one of the common chronic diseases affecting women's physical and mental health. Pregnancy and delivery are one of the main causes. Pelvic floor rehabilitation is a common method for the treatment of postpartum pelvic floor dysfunction, but it has some defects. Acupoint injection has advantages in the treatment of postpartum pelvic floor dysfunction, but there is a lack of standard clinical research to verify it. Therefore, the purpose of this randomized controlled trial is to evaluate the efficacy and safety of acupoint injection combined with pelvic floor rehabilitation in the treatment of postpartum pelvic floor disorders. METHODS: This is a prospective randomized controlled trial to study the efficacy and safety of acupoints injection combined with pelvic floor rehabilitation. And it is approved by the Ethics Committee of Clinical Research of our hospital. Patients were randomly divided into observation group (acupoint injection combined with pelvic floor rehabilitation group) or control group (pelvic floor rehabilitation group alone). The patients were followed up for 8 weeks after 12 weeks of treatment. The observation indexes included: pelvic organ prolapse degree, pelvic floor muscle strength, urinary incontinence score, adverse reactions, among others. Data were analyzed using the statistical software package SPSS version 18.0. CONCLUSIONS: This study will evaluate the efficacy and safety of acupoint injection combined with pelvic floor rehabilitation in the treatment of postpartum pelvic floor dysfunction, and provide reliable reference for the clinical application of this project. TRIAL REGISTRATION: OSF Registration number: DOI 10.17605/OSF.IO/VC65Z.


Asunto(s)
Terapia por Acupuntura/métodos , Terapia por Ejercicio/métodos , Trastornos del Suelo Pélvico , Trastornos Puerperales , Puntos de Acupuntura , Femenino , Humanos , Inyecciones , Trastornos del Suelo Pélvico/etiología , Trastornos del Suelo Pélvico/rehabilitación , Trastornos del Suelo Pélvico/terapia , Trastornos Puerperales/rehabilitación , Trastornos Puerperales/terapia , Resultado del Tratamiento
8.
Medicine (Baltimore) ; 100(17): e25683, 2021 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-33907140

RESUMEN

BACKGROUND: Postpartum urinary retention (PUR) is one of the most common complications after parturition which affect women's recovery after childbirth. Many clinical trials have shown that moxibustion, a traditional Chinese medicine therapy, is effective in treating PUR. But its effectiveness has not been evaluated scientifically and systematically. Therefore, this review aims to evaluate the safety and effectiveness of moxibustion therapy in treating patients with PUR. METHODS: We will search the following electronic databases, regardless of publication status and languages, from their respective inception dates to February 2021: the Cochrane Central Register of Controlled Trails, Pubmed, EMBASE, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, Chinese Scientific Journal Database, and Wan-Fang Database. Clinical randomized controlled trials (RCTs) related to moxibustion therapy for treating PUR will be included. Study selection, data collection, and quality assessment will be independently conducted by 2 researchers. For data synthesis, we will select either the fixed-effects or random-effects model according to heterogeneity assessment. Cure rates and postvoid residual volume (PVRV) will be the primary outcomes. The total effective rate and first urination time will be the second outcomes. Review Manager Software (RevMan) V.5.3 will be used if it is appropriate for meta-analysis. Otherwise, a systematic narrative synthesis will be conducted. The results will be presented as risk ratio (RR) with 95% confidence interval (CI) for dichotomous data and weight mean difference (WMD) or standard mean difference (SMD) 95% CI for continuous data. TRIAL REGISTRATION NUMBER: INPLASY 202140037.


Asunto(s)
Parto Obstétrico/efectos adversos , Moxibustión/métodos , Trastornos Puerperales/terapia , Retención Urinaria/terapia , Femenino , Humanos , Metaanálisis como Asunto , Embarazo , Trastornos Puerperales/etiología , Ensayos Clínicos Controlados Aleatorios como Asunto , Proyectos de Investigación , Revisiones Sistemáticas como Asunto , Resultado del Tratamiento , Retención Urinaria/etiología
9.
Clin Nutr ; 40(5): 3148-3157, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33386179

RESUMEN

BACKGROUND & AIMS: Gestational Diabetes Mellitus (GDM) is associated with a well-documented range of adverse pregnancy outcomes. The present meta-analysis was conducted to evaluate the effects of vitamin D supplementation on glycemic control and maternal-neonatal outcomes in women with established GDM. METHODS: Published literature was retrieved and screened from PubMed, Embase, Web of Science, CNKI (China National Knowledge Infrastructure), Wanfang, and Cochrane Center Register of Controlled Trails up to May 2020. RCTs of vitamin D supplementation on pregnant women with GDM were included. RESULTS: 19 RCTs (1550 participants) were eligible for meta-analyses. Overall, vitamin D supplementation significantly reduced serum fasting plasma glucose (FPG) (MD: -10.20 mg/dL, 95%CI: -13.43 to -6.96), insulin concentration (MD: -5.02 µIU/mL, 95%CI: -6.83 to -3.20) and the homeostasis model assessment of insulin resistance (HOMA-IR) (MD:-1.06, 95%CI: -1.40 to -0.72) in women with GDM. In addition, vitamin D supplementation in pregnant women with GDM significantly reduced adverse maternal outcomes including cesarean section (RR: 0.75, 95%CI: 0.63 to 0.89), maternal hospitalization (RR: 0.13, 95%CI: 0.02 to 0.98) and postpartum hemorrhage (RR: 0.47, 95%CI: 0.22 to 1.00). Several adverse neonatal complications including neonatal hyperbilirubinemia (RR: 0.47, 95%CI: 0.33 to 0.67), giant children (RR: 0.58, 95%CI: 0.38 to 0.89), polyhydramnios (RR: 0.42, 95% CI: 0.24 to 0.72), fetal distress (RR: 0.46, 95%CI: 0.24 to 0.90) and premature delivery (RR: 0.43, 95% CI: 0.26 to 0.72) were also significantly reduced. CONCLUSIONS: This meta-analysis suggested that supplementation of GDM women with vitamin D may lead to an improvement in glycemic control and reduction of adverse maternal-neonatal outcomes.


Asunto(s)
Diabetes Gestacional/tratamiento farmacológico , Suplementos Dietéticos , Control Glucémico , Enfermedades del Recién Nacido/prevención & control , Trastornos Puerperales/prevención & control , Vitamina D/farmacología , Vitaminas/farmacología , Glucemia/efectos de los fármacos , Diabetes Gestacional/epidemiología , Femenino , Humanos , Recién Nacido , Insulina/sangre , Embarazo , Vitamina D/administración & dosificación , Vitamina D/sangre , Vitaminas/administración & dosificación , Vitaminas/sangre
10.
Female Pelvic Med Reconstr Surg ; 27(1): e139-e145, 2021 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-32282522

RESUMEN

OBJECTIVES: Many women present for treatment of stress urinary incontinence (SUI) after childbirth. This systematic review describes the efficacy of treatment options for SUI initiated during the 12 months after delivery. METHODS: We conducted a systematic review to identify studies comparing treatment options for SUI initiated in the 12 months after parturition. We searched MEDLINE from inception to February 2019, using Medical Subject Heading terms related to pregnancy and urinary incontinence. Preintervention and postintervention populations were compared using analysis of variance with Fisher least significant difference method used to determine efficacy between groups. Grades for Recommendation, Assessment, Development and Evaluation system was used to categorize quality of evidence as high, moderate, low, or very low. RESULTS: We double screened 4548 abstracts, identifying 98 articles for full-text review. Seven studies met the eligibility criteria and were included. Compared with a control group, the 4 interventions identified outperformed the control group (P < 0.001) using Fisher (with effect sizes noted): (1) supervised pelvic floor physical therapy (0.76), (2) electrical stimulation (0.77), (3) home physical therapy (PT) (0.44), and (4) surgery (not applicable). Based on Grades for Recommendation, Assessment, Development and Evaluation assessment, there was moderate evidence to support PT and electrical stimulation, with insufficient evidence for surgery. There were no significant differences in parity, age, or body mass index via analysis of variance. The overall strength of evidence is poor for the treatment of postpartum SUI; more data are needed to fully evaluate other treatment options. CONCLUSIONS: All identified interventions demonstrated greater improvement for postpartum SUI over no treatment. Supervised PT ± electrostimulation was the most effective nonsurgical intervention.


Asunto(s)
Trastornos Puerperales/epidemiología , Trastornos Puerperales/terapia , Incontinencia Urinaria de Esfuerzo/epidemiología , Incontinencia Urinaria de Esfuerzo/terapia , Femenino , Humanos , Prevalencia
11.
Domest Anim Endocrinol ; 74: 106511, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-32739763

RESUMEN

Taurine is an abundant intracellular beta-amino acid majorly synthesized in the liver and transported through plasma. In mammals, taurine was reported to be involved in various physiological functions, including the enhancement of testosterone levels, the major estradiol precursor. Therefore, we hypothesize that taurine levels are associated with ovarian follicular steroids as well as with a reproductive problem called postpartum anestrus (PPA) in dairy buffaloes. To understand the taurine levels and its possible role in buffalo ovarian follicles, a correlation was established among taurine, estradiol, and testosterone levels in the ovarian follicular fluid. For this purpose, buffalo ovaries were obtained from the slaughterhouse, and follicular fluid samples were collected from small (<4 mm), medium (4-8 mm) and large (>8 mm) follicles. Taurine and steroid levels in the follicular fluid were analyzed by TLC and ELISA, respectively. Taurine and testosterone levels were significantly (P < 0.05) higher in the follicular fluid of small and medium follicles than large follicles, whereas the estradiol levels were significantly (P < 0.001) higher in the large follicles. Thus, taurine showed a positive correlation (r = 0.75) with testosterone and a negative correlation (r = -0.77) with estradiol in buffalo follicular fluid, indicating its possible role in testosterone function during follicular development. Interestingly, significantly (P < 0.001) lower plasma taurine levels in PPA (n = 50) than normal cyclic (n = 50) buffaloes represented its association with PPA. Therefore, our present study recommends the need for future nutrition studies on taurine supplementation to PPA buffaloes.


Asunto(s)
Anestro/fisiología , Búfalos , Líquido Folicular/química , Hormonas Esteroides Gonadales/análisis , Trastornos Puerperales/veterinaria , Taurina/análisis , Animales , Estradiol/análisis , Femenino , Folículo Ovárico/metabolismo , Periodo Posparto/fisiología , Trastornos Puerperales/metabolismo , Taurina/sangre , Testosterona/análisis
12.
BMC Cardiovasc Disord ; 20(1): 457, 2020 10 21.
Artículo en Inglés | MEDLINE | ID: mdl-33087055

RESUMEN

BACKGROUND: We studied the efficacy and safety of selenium supplementation in patients who had peripartum cardiomyopathy (PPCM) and selenium deficiency. METHODS: We randomly assigned 100 PPCM patients with left ventricular ejection fraction (LVEF) < 45% and selenium deficiency (< 70 µg/L) to receive either oral Selenium (L-selenomethionine) 200 µg/day for 3 months or nothing, in addition to recommended therapy, in an open-label randomised trial. The primary outcome was a composite of persistence of heart failure (HF) symptoms, unrecovered LV systolic function (LVEF < 55%) or death from any cause. RESULTS: Over a median of 19 months, the primary outcome occurred in 36 of 46 patients (78.3%) in the selenium group and in 43 of 54 patients (79.6%) in the control group (hazard ratio [HR] 0.69; 95% confidence interval [CI] 0.43-1.09; p = 0.113). Persistence of HF symptoms occurred in 18 patients (39.1%) in the selenium group and in 37 patients (68.5%) in the control group (HR 0.53; 95% CI 0.30-0.93; p = 0.006). LVEF < 55% occurred in 33 patients (71.7%) in the selenium group and in 38 patients (70.4%) in the control group (HR 0.91; 95% CI 0.57-1.45; p = 0.944). Death from any cause occurred in 3 patients (6.5%) in the selenium group and in 9 patients (16.7%) in the control group (HR 0.37; 95% CI 0.10-1.37; p = 0.137). CONCLUSIONS: In this study, selenium supplementation did not reduce the risk of the primary outcome, but it significantly reduced HF symptoms, and there was a trend towards a reduction of all-cause mortality. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03081949.


Asunto(s)
Cardiomiopatías/tratamiento farmacológico , Enfermedades Carenciales/tratamiento farmacológico , Suplementos Dietéticos , Insuficiencia Cardíaca/tratamiento farmacológico , Trastornos Puerperales/tratamiento farmacológico , Selenio/deficiencia , Selenometionina/uso terapéutico , Adulto , Cardiomiopatías/diagnóstico , Cardiomiopatías/mortalidad , Cardiomiopatías/fisiopatología , Enfermedades Carenciales/diagnóstico , Enfermedades Carenciales/mortalidad , Enfermedades Carenciales/fisiopatología , Suplementos Dietéticos/efectos adversos , Femenino , Insuficiencia Cardíaca/diagnóstico , Insuficiencia Cardíaca/mortalidad , Insuficiencia Cardíaca/fisiopatología , Humanos , Nigeria , Periodo Periparto , Embarazo , Prueba de Estudio Conceptual , Estudios Prospectivos , Trastornos Puerperales/diagnóstico , Trastornos Puerperales/mortalidad , Trastornos Puerperales/fisiopatología , Selenometionina/efectos adversos , Volumen Sistólico/efectos de los fármacos , Factores de Tiempo , Resultado del Tratamiento , Función Ventricular Izquierda/efectos de los fármacos , Adulto Joven
13.
J Manipulative Physiol Ther ; 43(7): 732-743, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32873418

RESUMEN

OBJECTIVE: The purpose of this study was to conduct a systematic review (SR) of the literature to assess the effectiveness of specific chiropractic care options commonly used for postpartum low back pain (LBP), pelvic girdle pain (PGP), or combination (LBP and PGP) pain. METHODS: A search strategy was developed. Interventions were those manual or other nonpharmacologic therapies commonly used by chiropractors (not requiring additional certifications). The outcomes were self-reported changes in pain or disability self-reported outcomes. We used the Scottish Intercollegiate Guideline Network checklists. Strength of the evidence (excluding cohort studies) was determined using an adapted version of the US Preventive Services Task Force criteria as described in the UK report. RESULTS: Of the 1611 published articles, 16 were included. These were 5 SRs, 10 randomized controlled trials (RCTs), and 1 cohort study. Postpartum LBP (1 RCT): moderate, favorable strength for spinal manipulation therapy/mobilization. Postpartum PGP (4 RCTs): moderate, unclear strength for exercise; and inconclusive, unclear strength for patient education. Postpartum LBP or PGP (3 SRs and 4 RCTs): inconclusive, unclear strength for exercise, self-management, and physiotherapy; while osteopathic manipulative therapy was inconclusive, favorable. CONCLUSION: No treatment option was identified as having sufficient evidence to make a clear recommendation. This SR identified a scarcity of literature regarding chiropractic care and back pain for postpartum women, as well as inconsistency among the terms LBP, PGP, and combination pain.


Asunto(s)
Dolor de la Región Lumbar/terapia , Manipulación Quiropráctica/estadística & datos numéricos , Dolor de Cintura Pélvica/terapia , Trastornos Puerperales/terapia , Adulto , Estudios de Cohortes , Femenino , Humanos , Periodo Posparto , Autoinforme
14.
J Ethnobiol Ethnomed ; 16(1): 28, 2020 May 24.
Artículo en Inglés | MEDLINE | ID: mdl-32448341

RESUMEN

BACKGROUND: The consumption of bear gallbladders and bear bile in Southeast Asia is a persistent threat to bear populations. As part of a larger effort to understand the characteristics of bear part consumption in Cambodia, we uncovered a consumer base of women seeking treatment for post-partum and uterine ailments. METHODS: To better understand this aspect of consumption, we interviewed 122 women in seven different provinces in Cambodia, probing into the motivations and influences for using bear bile, as well as what types of ailments Cambodian women use it for. RESULTS: We found that it is generally used by young or expecting mothers, and for such issues as post-partum "fatigue" (toas in Khmer), which could encompass post-partum depression. A desire to be supported by kin networks seems to facilitate the continued use of bear gallbladder and bile for these purposes. CONCLUSIONS: We suggest that efforts to reduce consumption should focus on encouraging older kin to change their means of support to Western/biomedical and by extension non-wildlife alternatives.


Asunto(s)
Bilis , Salud Materna , Ursidae , Animales , Productos Biológicos/uso terapéutico , Cambodia , Femenino , Humanos , Relaciones Intergeneracionales , Medicina Tradicional de Asia Oriental , Motivación , Periodo Posparto , Trastornos Puerperales/terapia , Enfermedades Uterinas/terapia
15.
Glob Health Sci Pract ; 8(1): 38-54, 2020 03 30.
Artículo en Inglés | MEDLINE | ID: mdl-32127359

RESUMEN

BACKGROUND: Coaching can improve the quality of care in primary-level birth facilities and promote birth attendant adherence to essential birth practices (EBPs) that reduce maternal and perinatal mortality. The intensity of coaching needed to promote and sustain behavior change is unknown. We investigated the relationship between coaching intensity, EBP adherence, and maternal and perinatal health outcomes using data from the BetterBirth Trial, which assessed the impact of a complex, coaching-based implementation of the World Health Organization's Safe Childbirth Checklist in Uttar Pradesh, India. METHODS: For each birth, we defined multiple coaching intensity metrics, including coaching frequency (coaching visits per month), cumulative coaching (total coaching visits accrued during the intervention), and scheduling adherence (coaching delivered as scheduled). We considered coaching delivered at both facility and birth attendant levels. We assessed the association between coaching intensity and birth attendant adherence to 18 EBPs and with maternal and perinatal health outcomes using regression models. RESULTS: Coaching frequency was associated with modestly increased EBP adherence. Delivering 6 coaching visits per month to facilities was associated with adherence to 1.3 additional EBPs (95% confidence interval [CI]=0.6, 1.9). High-frequency coaching delivered with high coverage among birth attendants was associated with greater improvements: providing 70% of birth attendants at a facility with at least 1 visit per month was associated with adherence to 2.0 additional EBPs (95% CI=1.0, 2.9). Neither cumulative coaching nor scheduling adherence was associated with EBP adherence. Coaching was generally not associated with health outcomes, possibly due to the small magnitude of association between coaching and EBP adherence. CONCLUSIONS: Frequent coaching may promote behavior change, especially if delivered with high coverage among birth attendants. However, the effects of coaching were modest and did not persist over time, suggesting that future coaching-based interventions should explore providing frequent coaching for longer periods.


Asunto(s)
Lista de Verificación , Adhesión a Directriz , Tutoría/métodos , Partería , Enfermeras y Enfermeros , Femenino , Instituciones de Salud , Humanos , India , Recién Nacido , Mortalidad Materna , Complicaciones del Trabajo de Parto/epidemiología , Parto , Mortalidad Perinatal , Embarazo , Trastornos Puerperales/epidemiología , Calidad de la Atención de Salud
16.
J Manipulative Physiol Ther ; 43(1): 68-77, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-32061416

RESUMEN

OBJECTIVE: The purpose of this study was to validate a Japanese version of the Pelvic Girdle Questionnaire (PGQ) and to confirm that the Japanese version of the PGQ (PGQ-J) was as valid as the original version. METHODS: This study involves 2 phases: (1) a cross-cultural adaptation study and (2) a cross-sectional study. The English PGQ was translated referring to the cross-cultural adaptation study process. Forty healthy pregnant or postpartum Japanese women participated. Women with pelvic girdle pain (PGP) completed the PGQ-J and 5 other instruments. Internal consistency, construct validity, test-retest reliability, ceiling and floor effects, and discrimination validity of the PGQ-J were analyzed. RESULTS: The PGQ-J showed high internal consistency with a Cronbach α of .968, and an interclass correlation coefficient of .79. The content validity showed a high positive correlation with the Oswestry Disability Index and Disability Rating Scale. CONCLUSION: The PGQ-J was reliable and valid with high internal consistency and content validity for assessing disability owing to PGP in Japanese pregnant and postpartum women. The PGQ-J is expected to facilitate research and clinical practice for PGP in Japan and contribute to the welfare of postpartum women.


Asunto(s)
Evaluación de la Discapacidad , Dolor de Cintura Pélvica/fisiopatología , Trastornos Puerperales/fisiopatología , Encuestas y Cuestionarios , Adulto , Estudios Transversales , Femenino , Humanos , Japón , Embarazo , Reproducibilidad de los Resultados , Traducciones
17.
BMC Womens Health ; 20(1): 37, 2020 02 27.
Artículo en Inglés | MEDLINE | ID: mdl-32103753

RESUMEN

BACKGROUND: Physiotherapists and midwives in primary healthcare often encounter women with an increased separation between the two rectus abdominis muscle bellies after pregnancy, a so-called increased inter recti distance (IRD). There are few studies on the contribution of increased IRD to the explanation of post-partum health complaints, and very little guidance in the literature for health professionals on the management of increased IRD. The aim of this study was to describe how physiotherapists and midwives in primary healthcare perceive the phenomenon of increased IRD and its management in women after childbirth. METHODS: A purposeful sampling approach was used to select physiotherapists and midwives working in primary healthcare in three large county council healthcare organisations in Sweden having experience of encountering women with increased IRD after pregnancy. Sixteen physiotherapists and midwives participated in focus group discussions. Four focus groups with four participants in each were undertaken. A semi-structured topic guide was used to explore responses to the research questions and the discussions were analysed using qualitative content analysis. RESULTS: We identified an overarching theme: Ambivalence towards the phenomenon increased IRD and frustration over insufficient professional knowledge. The theme included three categories: Uncertainty concerning the significance of increased IRD as a causal factor for functional problems; perceived insufficient professional knowledge base for the management of increased IRD; and lack of inter-professional collaboration and teamwork in the management of patients with increased IRD. Due to sparse and somewhat contradictory research findings and absence of clinical guidelines, the health professionals lacked basic preconditions for applying an evidence-based practice concerning increased IRD. They obtained their information about increased IRD from the media and fitness coaches, and hence were somewhat unsure about what to believe regarding the phenomenon. CONCLUSIONS: There was no consensus among the health professionals on how to best approach increased IRD in the clinical setting. Our findings stress the importance of more research to increase the professional knowledge base among physiotherapists and midwives. The findings highlight the urgent need for policies and clinical guidelines advising health professionals in the management of increased IRD and for facilitating inter-professional collaboration and teamwork.


Asunto(s)
Actitud del Personal de Salud , Parto Obstétrico/efectos adversos , Enfermeras Obstetrices/psicología , Fisioterapeutas/psicología , Trastornos Puerperales/terapia , Adulto , Femenino , Grupos Focales , Humanos , Partería/estadística & datos numéricos , Parto/fisiología , Periodo Posparto , Embarazo , Atención Primaria de Salud , Trastornos Puerperales/fisiopatología , Investigación Cualitativa , Recto del Abdomen/fisiopatología , Suecia
18.
Neurocrit Care ; 32(1): 348-352, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31571175
19.
J Ethnopharmacol ; 249: 112431, 2020 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-31783136

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Sheng-Hua-Tang (SHT) is commonly used to treat female illnesses, especially postpartum conditioning. However, its effects and mechanisms on female reproductive system remain unclear. The aim of the present study was to investigate the effect of SHT on female brain-ovary-uterus axis from bench to clinic. MATERIALS AND METHODS: Mice were administrated SHT (200 mg/kg) orally for seven consecutive days. Brain, ovary, and uterus tissues were then collected for microarray analysis. A nationwide database analysis and a pilot randomized, open-label clinical trial were further applied to evaluate the clinical application and effects of SHT on postpartum women. RESULTS: Microarray analysis showed that oral administration of SHT induced a cascade reaction of gene expression, with 17, 883, and 1592 genes were significantly regulated by SHT in brain, ovary, and uterus, respectively. Population-based analysis of one million subjects in Taiwan's National Health Insurance Research Database between 1997 and 2013 showed that SHT was commonly used in menstrual disorders in female population, especially dysmenorrhea, abnormal uterine bleeding, and variation of menstrual cycle. Clinical trial on postpartum women showed that oral administration SHT for one week alleviated uterine contraction pain and breast swelling pain. Furthermore, Mmp2, Mmp3, Mmp9, Mmp11, Mmp15, Oxtr, Plrl, and Tph2 gene expression affected by SHT in mice were correlated with clinical effects of SHT in human subjects. CONCLUSION: This report provided the scientific evidences of mechanisms and clinical efficacies of SHT. Moreover, our findings might afford insights for clinical doctors in terms of SHT prescription.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Mastodinia/tratamiento farmacológico , Trastornos de la Menstruación/tratamiento farmacológico , Trastornos Puerperales/tratamiento farmacológico , Administración Oral , Adolescente , Adulto , Animales , Encéfalo/efectos de los fármacos , Encéfalo/patología , Medicamentos Herbarios Chinos/uso terapéutico , Femenino , Perfilación de la Expresión Génica , Humanos , Ratones , Ovario/efectos de los fármacos , Ovario/patología , Proyectos Piloto , Periodo Posparto , Embarazo , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genética , Taiwán , Análisis de Matrices Tisulares , Contracción Uterina/efectos de los fármacos , Útero/efectos de los fármacos , Útero/patología , Adulto Joven
20.
J Obstet Gynaecol Can ; 42(2): 150-155, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31843289

RESUMEN

OBJECTIVE: This study aimed to quantify adverse neonatal outcomes in a cohort of registered midwife (RM)-attended conventional and water births in British Columbia. METHODS: The study included all term singleton births in British Columbia between January 1, 2005 and March 31, 2016 attended by RMs. Births were allocated to a conventional birth cohort or a water birth cohort according to where the actual birth of the neonate took place. The primary outcome was a composite adverse neonatal outcome (Apgar <7 at 5 minutes, resuscitation need, neonatal intensive care unit admission). Secondary outcomes included individual components of the primary outcome, maternal length of labour, and degree of perineal laceration (Canadian Task Force Classification Level II-2). RESULTS: The population included 25 798 births. Of these, 23 201 were conventional, and 2567 were water births. The rate of the composite adverse neonatal outcome was not higher in water births compared with conventional births (hospital conventional, 5.0%; hospital water, 4.2%; home conventional, 3.4%; and home water, 2.9%). Rates of individual components of the composite adverse neonatal score were not greater in the water birth cohort. Maternal outcomes included statistically shorter labours in the water birth cohort and no difference between the cohorts in incidence of third- and fourth-degree lacerations. CONCLUSION: Water births attended by RMs in British Columbia are not associated with higher rates of adverse neonatal outcomes than conventional births attended by midwives.


Asunto(s)
Parto Normal , Trastornos Puerperales/epidemiología , Adulto , Colombia Británica/epidemiología , Estudios de Cohortes , Femenino , Humanos , Recién Nacido , Enfermedades del Recién Nacido/epidemiología , Enfermedades del Recién Nacido/etiología , Masculino , Partería , Atención Perinatal , Embarazo , Resultado del Embarazo , Trastornos Puerperales/etiología , Sistema de Registros
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA